Here's Why Fulgent Genetics Is Skyrocketing 16.7% Today
New York City will use the company's COVID-19 test in its public school system.
Fulgent Genetics, Inc.
FLGT
FLGT
$35.85
$0.50
1.4%
Price as of October 23, 2020, 4:30 p.m. EDT
View Interactive FLGT Charts
Fulgent Genetics is a technology company that provides comprehensive diagnostic genetic testing using its proprietary platform, which integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes.
Interactive Chart
News & Analysis: Fulgent Genetics, Inc.
Nasdaq Falls 40; Fulgent, Fluidigm Collapse on COVID-19 Competition
The Nasdaq Composite failed to hit a record for the first time in a week.
Why Fulgent Genetics Is Crashing Today
Abbott's announcement of a new 15-minute COVID-19 test threatens recent revenue growth.
Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2020 Earnings Call Transcript
FLGT earnings call for the period ending June 30, 2020.
Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Call Transcript
FLGT earnings call for the period ending March 31, 2020.
Hypergrowth or Profits? These 3 Stocks Don't Make You Choose
These three companies are all growing like gangbusters and have already reached profitability.
3 Exciting Healthcare Stocks
We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.
